PDRN CareNiacinamide (Vitamin B3)
What is it?
Niacinamide, also known as nicotinamide, is the amide form of vitamin B3 (niacin) and one of the most versatile active ingredients in modern dermatology. As a precursor to the essential coenzymes NAD+ and NADP+, niacinamide plays a fundamental role in cellular energy metabolism, DNA repair, and over 400 enzymatic reactions in the body. In the skin, niacinamide supports the synthesis of ceramides and other intercellular lipids that form the skin barrier, regulates sebum production, inhibits melanosome transfer to reduce hyperpigmentation, and exerts anti-inflammatory effects by suppressing NF-κB-mediated cytokine release. It is one of the few ingredients with robust clinical evidence across multiple skin concerns: acne, hyperpigmentation, fine lines, enlarged pores, redness, and compromised barrier function. Niacinamide is water-soluble, stable across a wide pH range (4–7), compatible with virtually all other skincare actives, and well-tolerated even by sensitive skin at concentrations up to 5%. Higher concentrations (10%+) may cause mild irritation in some individuals. Its multi-pathway mechanism, extensive safety profile, and broad compatibility make it a staple in both clinical dermatology and consumer skincare formulations worldwide.
Role in PDRN
When paired with PDRN, niacinamide creates a powerful multi-target regenerative and protective combination. PDRN stimulates fibroblast proliferation and collagen synthesis through the adenosine A2A receptor pathway, while niacinamide supports these processes at the metabolic level by boosting NAD+ availability — the coenzyme that fibroblasts require for energy-intensive collagen production. Niacinamide's barrier-strengthening effect (increased ceramide synthesis) also helps the skin retain the hydration improvements generated by PDRN treatment. The anti-inflammatory actions of both ingredients are complementary: PDRN suppresses inflammation via adenosine receptor signaling, while niacinamide blocks NF-κB through a separate mechanism, providing broader inflammatory control than either ingredient alone. For hyperpigmentation concerns, niacinamide's ability to inhibit melanosome transfer pairs well with PDRN's tissue-regenerating effects to improve overall skin tone and clarity. In topical formulations, niacinamide and PDRN can be layered freely without stability or interaction concerns.
Clinical Data
Niacinamide has one of the largest bodies of clinical evidence among skincare actives. A landmark 2005 RCT published in the British Journal of Dermatology demonstrated that 5% topical niacinamide significantly reduced hyperpigmentation and improved skin lightness after 8 weeks compared to vehicle. A 2004 study in the International Journal of Cosmetic Science confirmed significant improvements in fine lines, wrinkles, hyperpigmentation, texture, and red blotchiness with 5% niacinamide over 12 weeks. For acne, a 2013 comparative trial showed 4% niacinamide gel was as effective as 1% clindamycin in reducing acne severity. Niacinamide's barrier-strengthening effect has been confirmed in multiple studies showing increased ceramide and free fatty acid levels in the stratum corneum after 4 weeks of use. When used alongside PDRN treatments, niacinamide helps optimize the skin environment for regeneration by maintaining barrier integrity and providing metabolic cofactors essential for the tissue repair processes PDRN initiates.